Proceedings From a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention Workshop to Control Hypertension

Yvonne Commodore-Mensah, Fleetwood Loustalot, Cheryl Dennison Himmelfarb, Patrice Desvigne-Nickens, Vandana Sachdev, Kirsten Bibbins-Domingo, Steven B. Clauser, Deborah J. Cohen, Brent M. Egan, A. Mark Fendrick, Keith C. Ferdinand, Cliff Goodman, Garth N. Graham, Marc G. Jaffe, Harlan M. Krumholz, Phillip D. Levy, Glen P. Mays, Robert Mcnellis, Paul Muntner, Gbenga OgedegbeRichard V. Milani, Linnea A. Polgreen, Lonny Reisman, Eduardo J. Sanchez, Laurence S. Sperling, Hilary K. Wall, Lori Whitten, Jackson T. Wright, Janet S. Wright, Lawrence J. Fine

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Hypertension treatment and control prevent more cardiovascular events than management of other modifiable risk factors. Although the age-adjusted proportion of US adults with controlled blood pressure (BP) defined as <140/90 mm Hg, improved from 31.8% in 1999-2000 to 48.5% in 2007-2008, it remained stable through 2013-2014 and declined to 43.7% in 2017-2018. To address the rapid decline in hypertension control, the National Heart, Lung, and Blood Institute and the Division for Heart Disease and Stroke Prevention of the Centers for Disease Control and Prevention convened a virtual workshop with multidisciplinary national experts. Also, the group sought to identify opportunities to reverse the adverse trend and further improve hypertension control. The workshop immediately preceded the Surgeon General's Call to Action to Control Hypertension, which recognized a stagnation in progress with hypertension control. The presentations and discussions included potential reasons for the decline and challenges in hypertension control, possible "big ideas,"and multisector approaches that could reverse the current trend while addressing knowledge gaps and research priorities. The broad set of "big ideas"was comprised of various activities that may improve hypertension control, including: interventions to engage patients, promotion of self-measured BP monitoring with clinical support, supporting team-based care, implementing telehealth, enhancing community-clinical linkages, advancing precision population health, developing tailored public health messaging, simplifying hypertension treatment, using process and outcomes quality metrics to foster accountability and efficiency, improving access to high-quality health care, addressing social determinants of health, supporting cardiovascular public health and research, and lowering financial barriers to hypertension control.

Original languageEnglish (US)
Pages (from-to)232-243
Number of pages12
JournalAmerican Journal of Hypertension
Volume35
Issue number3
DOIs
StatePublished - Mar 1 2022
Externally publishedYes

Keywords

  • blood pressure
  • cardiovascular disease
  • hypertension
  • prevention
  • screening

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Proceedings From a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention Workshop to Control Hypertension'. Together they form a unique fingerprint.

Cite this